End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,885 KRW | -0.10% | -3.27% | -14.30% |
2023 | Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding | CI |
2023 | Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 167,737 | 100.0 % | 187,155 | 100.0 % | +11.58% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 167,737 | 100.0 % | 187,155 | 100.0 % | +11.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hang-Gu Lee
CEO | Chief Executive Officer | 63 | - |
Chan-Sub Kim
BRD | Director/Board Member | 58 | 14/19/14 |
Yong-Hwa Lee
AUD | Comptroller/Controller/Auditor | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hang-Gu Lee
CEO | Chief Executive Officer | 63 | - |
Chan-Sub Kim
BRD | Director/Board Member | 58 | 14/19/14 |
Moon-Sung Lee
BRD | Director/Board Member | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,327,021 | 8,862,074 ( 57.82 %) | 313,630 ( 2.046 %) | 57.82 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
313,630 | 2.05% | 1,150,498 $ |
Company contact information
Korea Arlico Pharm Co., Ltd.
Arlico Pharmaceutical Building 7-21 Baumeo-ro 27-gil
06752, Seoul
+
http://www.arlico.co.krSector
1st Jan change | Capi. | |
---|---|---|
-14.30% | 54.14M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A260660 Stock
- Company Korea Arlico Pharm Co.,Ltd.